nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—ABCB1—hematologic cancer	0.105	1	CbGaD
Clarithromycin—CYP1A2—Anagrelide—hematologic cancer	0.0258	0.0422	CbGbCtD
Clarithromycin—ABCB1—Lenalidomide—hematologic cancer	0.0156	0.0256	CbGbCtD
Clarithromycin—CYP3A7—Ifosfamide—hematologic cancer	0.015	0.0246	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.015	0.0246	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0144	0.0235	CbGbCtD
Clarithromycin—CYP3A7—Imatinib—hematologic cancer	0.0144	0.0235	CbGbCtD
Clarithromycin—CYP3A5—Daunorubicin—hematologic cancer	0.0141	0.0231	CbGbCtD
Clarithromycin—CYP1A2—Carmustine—hematologic cancer	0.0135	0.0222	CbGbCtD
Clarithromycin—CYP3A5—Thalidomide—hematologic cancer	0.0128	0.021	CbGbCtD
Clarithromycin—SLC22A7—Methotrexate—hematologic cancer	0.0122	0.0201	CbGbCtD
Clarithromycin—CYP3A5—Teniposide—hematologic cancer	0.0122	0.02	CbGbCtD
Clarithromycin—CYP2C19—Bortezomib—hematologic cancer	0.0119	0.0194	CbGbCtD
Clarithromycin—CYP1A2—Methoxsalen—hematologic cancer	0.0115	0.0189	CbGbCtD
Clarithromycin—CYP3A5—Ifosfamide—hematologic cancer	0.0113	0.0185	CbGbCtD
Clarithromycin—CYP1A2—Bortezomib—hematologic cancer	0.011	0.0179	CbGbCtD
Clarithromycin—CYP3A5—Imatinib—hematologic cancer	0.0108	0.0177	CbGbCtD
Clarithromycin—CYP1A2—Daunorubicin—hematologic cancer	0.0105	0.0172	CbGbCtD
Clarithromycin—CYP2C19—Thalidomide—hematologic cancer	0.0103	0.0169	CbGbCtD
Clarithromycin—CYP1A2—Alitretinoin—hematologic cancer	0.0103	0.0168	CbGbCtD
Clarithromycin—CYP2C19—Teniposide—hematologic cancer	0.00987	0.0162	CbGbCtD
Clarithromycin—CYP1A2—Thalidomide—hematologic cancer	0.00954	0.0156	CbGbCtD
Clarithromycin—CYP3A4—Bexarotene—hematologic cancer	0.00936	0.0153	CbGbCtD
Clarithromycin—ABCB1—Daunorubicin—hematologic cancer	0.00916	0.015	CbGbCtD
Clarithromycin—CYP2C19—Ifosfamide—hematologic cancer	0.00911	0.0149	CbGbCtD
Clarithromycin—CYP3A7—Irinotecan—hematologic cancer	0.00898	0.0147	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00898	0.0147	CbGbCtD
Clarithromycin—ABCB1—Alitretinoin—hematologic cancer	0.00898	0.0147	CbGbCtD
Clarithromycin—CYP3A4—Busulfan—hematologic cancer	0.00871	0.0143	CbGbCtD
Clarithromycin—CYP3A4—Lomustine—hematologic cancer	0.00871	0.0143	CbGbCtD
Clarithromycin—CYP2C19—Imatinib—hematologic cancer	0.0087	0.0142	CbGbCtD
Clarithromycin—CYP3A5—Dasatinib—hematologic cancer	0.00866	0.0142	CbGbCtD
Clarithromycin—CYP1A2—Dacarbazine—hematologic cancer	0.00821	0.0134	CbGbCtD
Clarithromycin—CYP1A2—Imatinib—hematologic cancer	0.00803	0.0131	CbGbCtD
Clarithromycin—CYP3A7—Vincristine—hematologic cancer	0.00785	0.0129	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00785	0.0129	CbGbCtD
Clarithromycin—CYP3A4—Thiotepa—hematologic cancer	0.00776	0.0127	CbGbCtD
Clarithromycin—ABCB1—Imatinib—hematologic cancer	0.00702	0.0115	CbGbCtD
Clarithromycin—CYP3A5—Irinotecan—hematologic cancer	0.00674	0.011	CbGbCtD
Clarithromycin—CYP1A2—Dasatinib—hematologic cancer	0.00645	0.0106	CbGbCtD
Clarithromycin—ABCB1—Nilotinib—hematologic cancer	0.00638	0.0104	CbGbCtD
Clarithromycin—ABCB1—Vinorelbine—hematologic cancer	0.00632	0.0104	CbGbCtD
Clarithromycin—CYP3A4—Methoxsalen—hematologic cancer	0.00603	0.00988	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00591	0.00968	CbGbCtD
Clarithromycin—CYP3A7—Dexamethasone—hematologic cancer	0.00591	0.00968	CbGbCtD
Clarithromycin—CYP3A5—Vincristine—hematologic cancer	0.00589	0.00964	CbGbCtD
Clarithromycin—CYP3A4—Bortezomib—hematologic cancer	0.00574	0.0094	CbGbCtD
Clarithromycin—CYP2C19—Prednisone—hematologic cancer	0.00573	0.00939	CbGbCtD
Clarithromycin—ABCB1—Dasatinib—hematologic cancer	0.00564	0.00923	CbGbCtD
Clarithromycin—ABCB1—Mitoxantrone—hematologic cancer	0.00557	0.00912	CbGbCtD
Clarithromycin—CYP3A4—Daunorubicin—hematologic cancer	0.00549	0.00899	CbGbCtD
Clarithromycin—CYP3A5—Etoposide—hematologic cancer	0.00539	0.00883	CbGbCtD
Clarithromycin—ABCB1—Betamethasone—hematologic cancer	0.00496	0.00813	CbGbCtD
Clarithromycin—ABCB1—Gemcitabine—hematologic cancer	0.00492	0.00805	CbGbCtD
Clarithromycin—ABCB1—Prednisolone—hematologic cancer	0.0049	0.00802	CbGbCtD
Clarithromycin—CYP3A4—Cytarabine—hematologic cancer	0.00484	0.00793	CbGbCtD
Clarithromycin—CYP3A4—Teniposide—hematologic cancer	0.00477	0.00781	CbGbCtD
Clarithromycin—ABCB1—Prednisone—hematologic cancer	0.00462	0.00757	CbGbCtD
Clarithromycin—CYP3A5—Dexamethasone—hematologic cancer	0.00444	0.00726	CbGbCtD
Clarithromycin—CYP3A4—Ifosfamide—hematologic cancer	0.0044	0.00721	CbGbCtD
Clarithromycin—ABCB1—Irinotecan—hematologic cancer	0.00438	0.00718	CbGbCtD
Clarithromycin—CYP3A4—Imatinib—hematologic cancer	0.0042	0.00689	CbGbCtD
Clarithromycin—CYP1A2—Etoposide—hematologic cancer	0.00402	0.00658	CbGbCtD
Clarithromycin—CYP3A4—Ruxolitinib—hematologic cancer	0.00396	0.00648	CbGbCtD
Clarithromycin—ABCB1—Vinblastine—hematologic cancer	0.0039	0.00638	CbGbCtD
Clarithromycin—ABCB1—Vincristine—hematologic cancer	0.00383	0.00627	CbGbCtD
Clarithromycin—CYP3A4—Nilotinib—hematologic cancer	0.00382	0.00626	CbGbCtD
Clarithromycin—CYP3A4—Vinorelbine—hematologic cancer	0.00379	0.00621	CbGbCtD
Clarithromycin—CYP2C19—Dexamethasone—hematologic cancer	0.00358	0.00586	CbGbCtD
Clarithromycin—ABCB1—Cisplatin—hematologic cancer	0.00357	0.00585	CbGbCtD
Clarithromycin—ABCB1—Etoposide—hematologic cancer	0.00351	0.00575	CbGbCtD
Clarithromycin—CYP3A4—Triamcinolone—hematologic cancer	0.00347	0.00568	CbGbCtD
Clarithromycin—CYP3A4—Dasatinib—hematologic cancer	0.00338	0.00553	CbGbCtD
Clarithromycin—CYP3A4—Mitoxantrone—hematologic cancer	0.00334	0.00546	CbGbCtD
Clarithromycin—CYP3A4—Betamethasone—hematologic cancer	0.00297	0.00487	CbGbCtD
Clarithromycin—CYP3A4—Prednisolone—hematologic cancer	0.00293	0.0048	CbGbCtD
Clarithromycin—ABCB1—Dexamethasone—hematologic cancer	0.00289	0.00473	CbGbCtD
Clarithromycin—CYP3A4—Prednisone—hematologic cancer	0.00277	0.00454	CbGbCtD
Clarithromycin—CYP3A4—Irinotecan—hematologic cancer	0.00263	0.0043	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—hematologic cancer	0.00239	0.00392	CbGbCtD
Clarithromycin—CYP3A4—Vinblastine—hematologic cancer	0.00234	0.00382	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—hematologic cancer	0.00232	0.0038	CbGbCtD
Clarithromycin—CYP3A4—Vincristine—hematologic cancer	0.0023	0.00376	CbGbCtD
Clarithromycin—CYP3A4—Etoposide—hematologic cancer	0.0021	0.00345	CbGbCtD
Clarithromycin—CYP3A4—Dexamethasone—hematologic cancer	0.00173	0.00283	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—hematologic cancer	0.00143	0.00235	CbGbCtD
Clarithromycin—Roxithromycin—ABCB1—hematologic cancer	0.000139	0.291	CrCbGaD
Clarithromycin—Azithromycin—ABCB1—hematologic cancer	0.000139	0.291	CrCbGaD
Clarithromycin—Troleandomycin—ABCB1—hematologic cancer	0.000107	0.224	CrCbGaD
Clarithromycin—Erythromycin—ABCB1—hematologic cancer	9.3e-05	0.194	CrCbGaD
Clarithromycin—Visual impairment—Doxorubicin—hematologic cancer	2.05e-05	8.09e-05	CcSEcCtD
Clarithromycin—Nervous system disorder—Prednisone—hematologic cancer	2.05e-05	8.09e-05	CcSEcCtD
Clarithromycin—Skin disorder—Prednisone—hematologic cancer	2.03e-05	8.01e-05	CcSEcCtD
Clarithromycin—Nausea—Gemcitabine—hematologic cancer	2.03e-05	8e-05	CcSEcCtD
Clarithromycin—Vomiting—Cisplatin—hematologic cancer	2.02e-05	7.99e-05	CcSEcCtD
Clarithromycin—Hyperhidrosis—Prednisone—hematologic cancer	2.02e-05	7.97e-05	CcSEcCtD
Clarithromycin—Mental disorder—Epirubicin—hematologic cancer	2.02e-05	7.95e-05	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—hematologic cancer	2.01e-05	7.94e-05	CcSEcCtD
Clarithromycin—Rash—Cisplatin—hematologic cancer	2.01e-05	7.92e-05	CcSEcCtD
Clarithromycin—Dermatitis—Cisplatin—hematologic cancer	2e-05	7.91e-05	CcSEcCtD
Clarithromycin—Malnutrition—Epirubicin—hematologic cancer	2e-05	7.9e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Etoposide—hematologic cancer	2e-05	7.87e-05	CcSEcCtD
Clarithromycin—Anorexia—Prednisone—hematologic cancer	1.99e-05	7.86e-05	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—hematologic cancer	1.99e-05	7.85e-05	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—hematologic cancer	1.99e-05	7.84e-05	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—hematologic cancer	1.98e-05	7.83e-05	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—hematologic cancer	1.98e-05	7.81e-05	CcSEcCtD
Clarithromycin—Feeling abnormal—Betamethasone—hematologic cancer	1.98e-05	7.8e-05	CcSEcCtD
Clarithromycin—Feeling abnormal—Dexamethasone—hematologic cancer	1.98e-05	7.8e-05	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—hematologic cancer	1.98e-05	7.8e-05	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—hematologic cancer	1.98e-05	7.8e-05	CcSEcCtD
Clarithromycin—Flatulence—Epirubicin—hematologic cancer	1.97e-05	7.79e-05	CcSEcCtD
Clarithromycin—Tension—Epirubicin—hematologic cancer	1.97e-05	7.76e-05	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.96e-05	7.74e-05	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.96e-05	7.74e-05	CcSEcCtD
Clarithromycin—Dysgeusia—Epirubicin—hematologic cancer	1.96e-05	7.74e-05	CcSEcCtD
Clarithromycin—Hypersensitivity—Triamcinolone—hematologic cancer	1.95e-05	7.69e-05	CcSEcCtD
Clarithromycin—Nervousness—Epirubicin—hematologic cancer	1.95e-05	7.68e-05	CcSEcCtD
Clarithromycin—Back pain—Epirubicin—hematologic cancer	1.94e-05	7.64e-05	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—hematologic cancer	1.93e-05	7.62e-05	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—hematologic cancer	1.93e-05	7.62e-05	CcSEcCtD
Clarithromycin—Dizziness—Etoposide—hematologic cancer	1.93e-05	7.61e-05	CcSEcCtD
Clarithromycin—Muscle spasms—Epirubicin—hematologic cancer	1.93e-05	7.6e-05	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—hematologic cancer	1.92e-05	7.59e-05	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—hematologic cancer	1.92e-05	7.59e-05	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—hematologic cancer	1.92e-05	7.57e-05	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—hematologic cancer	1.92e-05	7.56e-05	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—hematologic cancer	1.91e-05	7.54e-05	CcSEcCtD
Clarithromycin—Urticaria—Dexamethasone—hematologic cancer	1.91e-05	7.52e-05	CcSEcCtD
Clarithromycin—Urticaria—Betamethasone—hematologic cancer	1.91e-05	7.52e-05	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.9e-05	7.51e-05	CcSEcCtD
Clarithromycin—Dizziness—Prednisolone—hematologic cancer	1.9e-05	7.5e-05	CcSEcCtD
Clarithromycin—Asthenia—Triamcinolone—hematologic cancer	1.9e-05	7.49e-05	CcSEcCtD
Clarithromycin—Abdominal pain—Betamethasone—hematologic cancer	1.9e-05	7.49e-05	CcSEcCtD
Clarithromycin—Abdominal pain—Dexamethasone—hematologic cancer	1.9e-05	7.49e-05	CcSEcCtD
Clarithromycin—Body temperature increased—Dexamethasone—hematologic cancer	1.9e-05	7.49e-05	CcSEcCtD
Clarithromycin—Body temperature increased—Betamethasone—hematologic cancer	1.9e-05	7.49e-05	CcSEcCtD
Clarithromycin—Nausea—Cisplatin—hematologic cancer	1.89e-05	7.46e-05	CcSEcCtD
Clarithromycin—Insomnia—Prednisone—hematologic cancer	1.89e-05	7.46e-05	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisone—hematologic cancer	1.88e-05	7.41e-05	CcSEcCtD
Clarithromycin—Pruritus—Triamcinolone—hematologic cancer	1.87e-05	7.38e-05	CcSEcCtD
Clarithromycin—Cough—Methotrexate—hematologic cancer	1.87e-05	7.37e-05	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—hematologic cancer	1.86e-05	7.36e-05	CcSEcCtD
Clarithromycin—Ill-defined disorder—Epirubicin—hematologic cancer	1.86e-05	7.33e-05	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—hematologic cancer	1.85e-05	7.32e-05	CcSEcCtD
Clarithromycin—Vomiting—Etoposide—hematologic cancer	1.85e-05	7.32e-05	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—hematologic cancer	1.85e-05	7.31e-05	CcSEcCtD
Clarithromycin—Anaemia—Epirubicin—hematologic cancer	1.85e-05	7.3e-05	CcSEcCtD
Clarithromycin—Agitation—Epirubicin—hematologic cancer	1.84e-05	7.26e-05	CcSEcCtD
Clarithromycin—Dyspepsia—Prednisone—hematologic cancer	1.84e-05	7.26e-05	CcSEcCtD
Clarithromycin—Rash—Etoposide—hematologic cancer	1.84e-05	7.25e-05	CcSEcCtD
Clarithromycin—Dermatitis—Etoposide—hematologic cancer	1.84e-05	7.25e-05	CcSEcCtD
Clarithromycin—Headache—Etoposide—hematologic cancer	1.83e-05	7.21e-05	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—hematologic cancer	1.83e-05	7.21e-05	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—hematologic cancer	1.82e-05	7.19e-05	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—hematologic cancer	1.82e-05	7.19e-05	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—hematologic cancer	1.82e-05	7.18e-05	CcSEcCtD
Clarithromycin—Decreased appetite—Prednisone—hematologic cancer	1.82e-05	7.17e-05	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—hematologic cancer	1.81e-05	7.16e-05	CcSEcCtD
Clarithromycin—Rash—Prednisolone—hematologic cancer	1.81e-05	7.16e-05	CcSEcCtD
Clarithromycin—Dermatitis—Prednisolone—hematologic cancer	1.81e-05	7.15e-05	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.81e-05	7.14e-05	CcSEcCtD
Clarithromycin—Malaise—Epirubicin—hematologic cancer	1.81e-05	7.13e-05	CcSEcCtD
Clarithromycin—Fatigue—Prednisone—hematologic cancer	1.8e-05	7.11e-05	CcSEcCtD
Clarithromycin—Headache—Prednisolone—hematologic cancer	1.8e-05	7.11e-05	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—hematologic cancer	1.8e-05	7.1e-05	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—hematologic cancer	1.8e-05	7.1e-05	CcSEcCtD
Clarithromycin—Vertigo—Epirubicin—hematologic cancer	1.8e-05	7.1e-05	CcSEcCtD
Clarithromycin—Leukopenia—Epirubicin—hematologic cancer	1.79e-05	7.07e-05	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—hematologic cancer	1.79e-05	7.07e-05	CcSEcCtD
Clarithromycin—Constipation—Prednisone—hematologic cancer	1.79e-05	7.05e-05	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—hematologic cancer	1.78e-05	7.03e-05	CcSEcCtD
Clarithromycin—Palpitations—Epirubicin—hematologic cancer	1.77e-05	6.98e-05	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—hematologic cancer	1.76e-05	6.95e-05	CcSEcCtD
Clarithromycin—Loss of consciousness—Epirubicin—hematologic cancer	1.76e-05	6.95e-05	CcSEcCtD
Clarithromycin—Dizziness—Triamcinolone—hematologic cancer	1.75e-05	6.9e-05	CcSEcCtD
Clarithromycin—Cough—Epirubicin—hematologic cancer	1.75e-05	6.9e-05	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—hematologic cancer	1.75e-05	6.89e-05	CcSEcCtD
Clarithromycin—Convulsion—Epirubicin—hematologic cancer	1.74e-05	6.85e-05	CcSEcCtD
Clarithromycin—Infection—Methotrexate—hematologic cancer	1.74e-05	6.85e-05	CcSEcCtD
Clarithromycin—Nausea—Etoposide—hematologic cancer	1.73e-05	6.83e-05	CcSEcCtD
Clarithromycin—Feeling abnormal—Prednisone—hematologic cancer	1.72e-05	6.8e-05	CcSEcCtD
Clarithromycin—Asthenia—Dexamethasone—hematologic cancer	1.72e-05	6.79e-05	CcSEcCtD
Clarithromycin—Asthenia—Betamethasone—hematologic cancer	1.72e-05	6.79e-05	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.72e-05	6.78e-05	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—hematologic cancer	1.71e-05	6.76e-05	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—hematologic cancer	1.71e-05	6.76e-05	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—hematologic cancer	1.71e-05	6.75e-05	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Prednisone—hematologic cancer	1.71e-05	6.74e-05	CcSEcCtD
Clarithromycin—Nausea—Prednisolone—hematologic cancer	1.71e-05	6.74e-05	CcSEcCtD
Clarithromycin—Myalgia—Epirubicin—hematologic cancer	1.71e-05	6.73e-05	CcSEcCtD
Clarithromycin—Chest pain—Epirubicin—hematologic cancer	1.71e-05	6.73e-05	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—hematologic cancer	1.7e-05	6.72e-05	CcSEcCtD
Clarithromycin—Anxiety—Epirubicin—hematologic cancer	1.7e-05	6.7e-05	CcSEcCtD
Clarithromycin—Pruritus—Dexamethasone—hematologic cancer	1.7e-05	6.7e-05	CcSEcCtD
Clarithromycin—Pruritus—Betamethasone—hematologic cancer	1.7e-05	6.7e-05	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—hematologic cancer	1.7e-05	6.69e-05	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.69e-05	6.68e-05	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—hematologic cancer	1.69e-05	6.66e-05	CcSEcCtD
Clarithromycin—Discomfort—Epirubicin—hematologic cancer	1.68e-05	6.65e-05	CcSEcCtD
Clarithromycin—Vomiting—Triamcinolone—hematologic cancer	1.68e-05	6.64e-05	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—hematologic cancer	1.67e-05	6.59e-05	CcSEcCtD
Clarithromycin—Rash—Triamcinolone—hematologic cancer	1.67e-05	6.58e-05	CcSEcCtD
Clarithromycin—Dry mouth—Epirubicin—hematologic cancer	1.67e-05	6.58e-05	CcSEcCtD
Clarithromycin—Dermatitis—Triamcinolone—hematologic cancer	1.67e-05	6.57e-05	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—hematologic cancer	1.66e-05	6.57e-05	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—hematologic cancer	1.66e-05	6.57e-05	CcSEcCtD
Clarithromycin—Urticaria—Prednisone—hematologic cancer	1.66e-05	6.55e-05	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—hematologic cancer	1.66e-05	6.55e-05	CcSEcCtD
Clarithromycin—Headache—Triamcinolone—hematologic cancer	1.66e-05	6.54e-05	CcSEcCtD
Clarithromycin—Abdominal pain—Prednisone—hematologic cancer	1.65e-05	6.52e-05	CcSEcCtD
Clarithromycin—Body temperature increased—Prednisone—hematologic cancer	1.65e-05	6.52e-05	CcSEcCtD
Clarithromycin—Confusional state—Epirubicin—hematologic cancer	1.65e-05	6.5e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Dexamethasone—hematologic cancer	1.64e-05	6.48e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Betamethasone—hematologic cancer	1.64e-05	6.48e-05	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—hematologic cancer	1.64e-05	6.46e-05	CcSEcCtD
Clarithromycin—Anaphylactic shock—Epirubicin—hematologic cancer	1.63e-05	6.45e-05	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—hematologic cancer	1.63e-05	6.43e-05	CcSEcCtD
Clarithromycin—Infection—Epirubicin—hematologic cancer	1.62e-05	6.41e-05	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—hematologic cancer	1.62e-05	6.38e-05	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—hematologic cancer	1.61e-05	6.34e-05	CcSEcCtD
Clarithromycin—Nervous system disorder—Epirubicin—hematologic cancer	1.6e-05	6.33e-05	CcSEcCtD
Clarithromycin—Thrombocytopenia—Epirubicin—hematologic cancer	1.6e-05	6.31e-05	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.59e-05	6.28e-05	CcSEcCtD
Clarithromycin—Skin disorder—Epirubicin—hematologic cancer	1.59e-05	6.26e-05	CcSEcCtD
Clarithromycin—Dizziness—Betamethasone—hematologic cancer	1.59e-05	6.26e-05	CcSEcCtD
Clarithromycin—Dizziness—Dexamethasone—hematologic cancer	1.59e-05	6.26e-05	CcSEcCtD
Clarithromycin—Hyperhidrosis—Epirubicin—hematologic cancer	1.58e-05	6.24e-05	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—hematologic cancer	1.58e-05	6.23e-05	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—hematologic cancer	1.58e-05	6.23e-05	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—hematologic cancer	1.58e-05	6.23e-05	CcSEcCtD
Clarithromycin—Anxiety—Doxorubicin—hematologic cancer	1.57e-05	6.2e-05	CcSEcCtD
Clarithromycin—Nausea—Triamcinolone—hematologic cancer	1.57e-05	6.2e-05	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—hematologic cancer	1.57e-05	6.19e-05	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.57e-05	6.18e-05	CcSEcCtD
Clarithromycin—Discomfort—Doxorubicin—hematologic cancer	1.56e-05	6.15e-05	CcSEcCtD
Clarithromycin—Anorexia—Epirubicin—hematologic cancer	1.56e-05	6.15e-05	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—hematologic cancer	1.56e-05	6.14e-05	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—hematologic cancer	1.55e-05	6.13e-05	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—hematologic cancer	1.54e-05	6.09e-05	CcSEcCtD
Clarithromycin—Hypersensitivity—Prednisone—hematologic cancer	1.54e-05	6.08e-05	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—hematologic cancer	1.54e-05	6.07e-05	CcSEcCtD
Clarithromycin—Vomiting—Dexamethasone—hematologic cancer	1.53e-05	6.02e-05	CcSEcCtD
Clarithromycin—Vomiting—Betamethasone—hematologic cancer	1.53e-05	6.02e-05	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—hematologic cancer	1.52e-05	6.02e-05	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—hematologic cancer	1.52e-05	5.99e-05	CcSEcCtD
Clarithromycin—Rash—Betamethasone—hematologic cancer	1.51e-05	5.97e-05	CcSEcCtD
Clarithromycin—Rash—Dexamethasone—hematologic cancer	1.51e-05	5.97e-05	CcSEcCtD
Clarithromycin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.51e-05	5.97e-05	CcSEcCtD
Clarithromycin—Dermatitis—Betamethasone—hematologic cancer	1.51e-05	5.97e-05	CcSEcCtD
Clarithromycin—Dermatitis—Dexamethasone—hematologic cancer	1.51e-05	5.97e-05	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.51e-05	5.95e-05	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—hematologic cancer	1.51e-05	5.94e-05	CcSEcCtD
Clarithromycin—Headache—Betamethasone—hematologic cancer	1.5e-05	5.93e-05	CcSEcCtD
Clarithromycin—Headache—Dexamethasone—hematologic cancer	1.5e-05	5.93e-05	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—hematologic cancer	1.5e-05	5.93e-05	CcSEcCtD
Clarithromycin—Asthenia—Prednisone—hematologic cancer	1.5e-05	5.92e-05	CcSEcCtD
Clarithromycin—Pain—Methotrexate—hematologic cancer	1.49e-05	5.89e-05	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.49e-05	5.88e-05	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—hematologic cancer	1.48e-05	5.85e-05	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.48e-05	5.84e-05	CcSEcCtD
Clarithromycin—Pruritus—Prednisone—hematologic cancer	1.48e-05	5.83e-05	CcSEcCtD
Clarithromycin—Insomnia—Epirubicin—hematologic cancer	1.48e-05	5.83e-05	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—hematologic cancer	1.47e-05	5.8e-05	CcSEcCtD
Clarithromycin—Paraesthesia—Epirubicin—hematologic cancer	1.47e-05	5.79e-05	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.46e-05	5.77e-05	CcSEcCtD
Clarithromycin—Dyspnoea—Epirubicin—hematologic cancer	1.46e-05	5.75e-05	CcSEcCtD
Clarithromycin—Somnolence—Epirubicin—hematologic cancer	1.45e-05	5.73e-05	CcSEcCtD
Clarithromycin—Anorexia—Doxorubicin—hematologic cancer	1.44e-05	5.69e-05	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—hematologic cancer	1.44e-05	5.68e-05	CcSEcCtD
Clarithromycin—Dyspepsia—Epirubicin—hematologic cancer	1.44e-05	5.68e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Prednisone—hematologic cancer	1.43e-05	5.64e-05	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.43e-05	5.64e-05	CcSEcCtD
Clarithromycin—Nausea—Betamethasone—hematologic cancer	1.43e-05	5.62e-05	CcSEcCtD
Clarithromycin—Nausea—Dexamethasone—hematologic cancer	1.43e-05	5.62e-05	CcSEcCtD
Clarithromycin—Decreased appetite—Epirubicin—hematologic cancer	1.42e-05	5.61e-05	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.41e-05	5.57e-05	CcSEcCtD
Clarithromycin—Fatigue—Epirubicin—hematologic cancer	1.41e-05	5.56e-05	CcSEcCtD
Clarithromycin—Constipation—Epirubicin—hematologic cancer	1.4e-05	5.52e-05	CcSEcCtD
Clarithromycin—Pain—Epirubicin—hematologic cancer	1.4e-05	5.52e-05	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—hematologic cancer	1.39e-05	5.48e-05	CcSEcCtD
Clarithromycin—Dizziness—Prednisone—hematologic cancer	1.38e-05	5.45e-05	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—hematologic cancer	1.38e-05	5.45e-05	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—hematologic cancer	1.38e-05	5.45e-05	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.38e-05	5.44e-05	CcSEcCtD
Clarithromycin—Insomnia—Doxorubicin—hematologic cancer	1.37e-05	5.4e-05	CcSEcCtD
Clarithromycin—Paraesthesia—Doxorubicin—hematologic cancer	1.36e-05	5.36e-05	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—hematologic cancer	1.35e-05	5.32e-05	CcSEcCtD
Clarithromycin—Feeling abnormal—Epirubicin—hematologic cancer	1.35e-05	5.31e-05	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—hematologic cancer	1.34e-05	5.31e-05	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.34e-05	5.27e-05	CcSEcCtD
Clarithromycin—Dyspepsia—Doxorubicin—hematologic cancer	1.33e-05	5.25e-05	CcSEcCtD
Clarithromycin—Vomiting—Prednisone—hematologic cancer	1.33e-05	5.24e-05	CcSEcCtD
Clarithromycin—Rash—Prednisone—hematologic cancer	1.32e-05	5.2e-05	CcSEcCtD
Clarithromycin—Dermatitis—Prednisone—hematologic cancer	1.32e-05	5.19e-05	CcSEcCtD
Clarithromycin—Decreased appetite—Doxorubicin—hematologic cancer	1.31e-05	5.19e-05	CcSEcCtD
Clarithromycin—Headache—Prednisone—hematologic cancer	1.31e-05	5.17e-05	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.31e-05	5.15e-05	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—hematologic cancer	1.3e-05	5.15e-05	CcSEcCtD
Clarithromycin—Urticaria—Epirubicin—hematologic cancer	1.3e-05	5.12e-05	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—hematologic cancer	1.29e-05	5.1e-05	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—hematologic cancer	1.29e-05	5.1e-05	CcSEcCtD
Clarithromycin—Abdominal pain—Epirubicin—hematologic cancer	1.29e-05	5.1e-05	CcSEcCtD
Clarithromycin—Body temperature increased—Epirubicin—hematologic cancer	1.29e-05	5.1e-05	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—hematologic cancer	1.29e-05	5.08e-05	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—hematologic cancer	1.25e-05	4.94e-05	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—hematologic cancer	1.25e-05	4.92e-05	CcSEcCtD
Clarithromycin—Nausea—Prednisone—hematologic cancer	1.24e-05	4.9e-05	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.24e-05	4.88e-05	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—hematologic cancer	1.24e-05	4.88e-05	CcSEcCtD
Clarithromycin—Hypersensitivity—Epirubicin—hematologic cancer	1.2e-05	4.75e-05	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—hematologic cancer	1.2e-05	4.74e-05	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—hematologic cancer	1.2e-05	4.72e-05	CcSEcCtD
Clarithromycin—Abdominal pain—Doxorubicin—hematologic cancer	1.2e-05	4.72e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—hematologic cancer	1.19e-05	4.72e-05	CcSEcCtD
Clarithromycin—Asthenia—Epirubicin—hematologic cancer	1.17e-05	4.63e-05	CcSEcCtD
Clarithromycin—Pruritus—Epirubicin—hematologic cancer	1.16e-05	4.56e-05	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—hematologic cancer	1.15e-05	4.56e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Epirubicin—hematologic cancer	1.12e-05	4.41e-05	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—hematologic cancer	1.11e-05	4.4e-05	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—hematologic cancer	1.11e-05	4.38e-05	CcSEcCtD
Clarithromycin—Rash—Methotrexate—hematologic cancer	1.1e-05	4.35e-05	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—hematologic cancer	1.1e-05	4.34e-05	CcSEcCtD
Clarithromycin—Headache—Methotrexate—hematologic cancer	1.09e-05	4.32e-05	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—hematologic cancer	1.09e-05	4.28e-05	CcSEcCtD
Clarithromycin—Dizziness—Epirubicin—hematologic cancer	1.08e-05	4.27e-05	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—hematologic cancer	1.07e-05	4.22e-05	CcSEcCtD
Clarithromycin—Vomiting—Epirubicin—hematologic cancer	1.04e-05	4.1e-05	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—hematologic cancer	1.04e-05	4.09e-05	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—hematologic cancer	1.03e-05	4.08e-05	CcSEcCtD
Clarithromycin—Rash—Epirubicin—hematologic cancer	1.03e-05	4.07e-05	CcSEcCtD
Clarithromycin—Dermatitis—Epirubicin—hematologic cancer	1.03e-05	4.06e-05	CcSEcCtD
Clarithromycin—Headache—Epirubicin—hematologic cancer	1.02e-05	4.04e-05	CcSEcCtD
Clarithromycin—Dizziness—Doxorubicin—hematologic cancer	1e-05	3.95e-05	CcSEcCtD
Clarithromycin—Nausea—Epirubicin—hematologic cancer	9.71e-06	3.83e-05	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—hematologic cancer	9.62e-06	3.79e-05	CcSEcCtD
Clarithromycin—Rash—Doxorubicin—hematologic cancer	9.54e-06	3.76e-05	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—hematologic cancer	9.53e-06	3.76e-05	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—hematologic cancer	9.47e-06	3.74e-05	CcSEcCtD
Clarithromycin—Nausea—Doxorubicin—hematologic cancer	8.98e-06	3.54e-05	CcSEcCtD
Clarithromycin—CYP2C19—Metabolism—ARNTL—hematologic cancer	7.13e-06	0.000231	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HDC—hematologic cancer	7.07e-06	0.000229	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYCS—hematologic cancer	7.03e-06	0.000228	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.02e-06	0.000227	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	6.99e-06	0.000226	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NCOA3—hematologic cancer	6.99e-06	0.000226	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ADCY7—hematologic cancer	6.99e-06	0.000226	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ARNTL—hematologic cancer	6.96e-06	0.000225	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NUP214—hematologic cancer	6.94e-06	0.000225	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CA9—hematologic cancer	6.93e-06	0.000225	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ACP5—hematologic cancer	6.93e-06	0.000225	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NCOR2—hematologic cancer	6.84e-06	0.000222	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	6.83e-06	0.000221	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	6.81e-06	0.000221	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ABCG2—hematologic cancer	6.8e-06	0.00022	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—MTR—hematologic cancer	6.8e-06	0.00022	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ACP5—hematologic cancer	6.77e-06	0.000219	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CA9—hematologic cancer	6.77e-06	0.000219	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NCOR2—hematologic cancer	6.68e-06	0.000216	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ENO2—hematologic cancer	6.66e-06	0.000216	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—IDH1—hematologic cancer	6.52e-06	0.000211	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CDA—hematologic cancer	6.47e-06	0.00021	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTT1—hematologic cancer	6.46e-06	0.000209	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTO1—hematologic cancer	6.44e-06	0.000209	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TXN—hematologic cancer	6.44e-06	0.000209	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ABCC3—hematologic cancer	6.44e-06	0.000209	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—IDH1—hematologic cancer	6.36e-06	0.000206	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.36e-06	0.000206	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—FHL2—hematologic cancer	6.35e-06	0.000206	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SDC1—hematologic cancer	6.32e-06	0.000205	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.31e-06	0.000204	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SPHK1—hematologic cancer	6.31e-06	0.000204	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TXN—hematologic cancer	6.29e-06	0.000204	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTO1—hematologic cancer	6.29e-06	0.000204	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ABCC3—hematologic cancer	6.29e-06	0.000204	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—AGRN—hematologic cancer	6.23e-06	0.000202	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PC—hematologic cancer	6.23e-06	0.000202	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTP1—hematologic cancer	6.2e-06	0.000201	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SPHK1—hematologic cancer	6.16e-06	0.000199	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—UGT1A1—hematologic cancer	6.06e-06	0.000196	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GBA—hematologic cancer	6.01e-06	0.000195	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.01e-06	0.000195	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—UGT1A1—hematologic cancer	5.91e-06	0.000192	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—IDH2—hematologic cancer	5.91e-06	0.000191	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HMMR—hematologic cancer	5.91e-06	0.000191	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.89e-06	0.000191	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.89e-06	0.000191	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ABCB1—hematologic cancer	5.87e-06	0.00019	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.79e-06	0.000188	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SLC22A1—hematologic cancer	5.75e-06	0.000186	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CRABP1—hematologic cancer	5.75e-06	0.000186	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.74e-06	0.000186	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTM1—hematologic cancer	5.7e-06	0.000185	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NCOR1—hematologic cancer	5.7e-06	0.000185	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALOX5—hematologic cancer	5.61e-06	0.000182	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.61e-06	0.000182	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.57e-06	0.00018	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NUP98—hematologic cancer	5.56e-06	0.00018	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.55e-06	0.00018	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—MTAP—hematologic cancer	5.5e-06	0.000178	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NUP98—hematologic cancer	5.43e-06	0.000176	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CA9—hematologic cancer	5.4e-06	0.000175	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ACP5—hematologic cancer	5.4e-06	0.000175	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.4e-06	0.000175	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.4e-06	0.000175	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CD44—hematologic cancer	5.37e-06	0.000174	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NQO1—hematologic cancer	5.37e-06	0.000174	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NUP214—hematologic cancer	5.36e-06	0.000174	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.33e-06	0.000173	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.31e-06	0.000172	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ADCY7—hematologic cancer	5.27e-06	0.000171	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NCOA3—hematologic cancer	5.27e-06	0.000171	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ABCG2—hematologic cancer	5.25e-06	0.00017	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—MTR—hematologic cancer	5.25e-06	0.00017	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NUP214—hematologic cancer	5.23e-06	0.00017	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ENO2—hematologic cancer	5.15e-06	0.000167	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ABCG2—hematologic cancer	5.13e-06	0.000166	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—MTR—hematologic cancer	5.13e-06	0.000166	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYCS—hematologic cancer	5.08e-06	0.000165	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—IDH1—hematologic cancer	5.08e-06	0.000165	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.05e-06	0.000164	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—MTHFR—hematologic cancer	5.03e-06	0.000163	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ENO2—hematologic cancer	5.03e-06	0.000163	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TXN—hematologic cancer	5.02e-06	0.000163	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.02e-06	0.000163	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.02e-06	0.000163	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTT1—hematologic cancer	5e-06	0.000162	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.92e-06	0.000159	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.91e-06	0.000159	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—FHL2—hematologic cancer	4.9e-06	0.000159	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SDC1—hematologic cancer	4.88e-06	0.000158	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTT1—hematologic cancer	4.88e-06	0.000158	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—AGRN—hematologic cancer	4.81e-06	0.000156	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SDC1—hematologic cancer	4.77e-06	0.000154	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.73e-06	0.000153	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.72e-06	0.000153	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.67e-06	0.000151	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.61e-06	0.000149	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.59e-06	0.000149	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.59e-06	0.000149	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.57e-06	0.000148	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—IDH2—hematologic cancer	4.56e-06	0.000148	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HMMR—hematologic cancer	4.56e-06	0.000148	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.48e-06	0.000145	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.48e-06	0.000145	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.41e-06	0.000143	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NUP98—hematologic cancer	4.33e-06	0.00014	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.29e-06	0.000139	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.27e-06	0.000138	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.24e-06	0.000137	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.23e-06	0.000137	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.21e-06	0.000136	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.21e-06	0.000136	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NUP214—hematologic cancer	4.18e-06	0.000135	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CA9—hematologic cancer	4.17e-06	0.000135	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ACP5—hematologic cancer	4.17e-06	0.000135	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CD44—hematologic cancer	4.15e-06	0.000135	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NQO1—hematologic cancer	4.15e-06	0.000135	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.13e-06	0.000134	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.12e-06	0.000133	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.12e-06	0.000133	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.11e-06	0.000133	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.09e-06	0.000133	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—MTR—hematologic cancer	4.09e-06	0.000133	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.07e-06	0.000132	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NQO1—hematologic cancer	4.05e-06	0.000131	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CD44—hematologic cancer	4.05e-06	0.000131	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ENO2—hematologic cancer	4.01e-06	0.00013	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYCS—hematologic cancer	3.93e-06	0.000127	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.92e-06	0.000127	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—IDH1—hematologic cancer	3.92e-06	0.000127	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.9e-06	0.000127	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.89e-06	0.000126	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TXN—hematologic cancer	3.88e-06	0.000126	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.88e-06	0.000126	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.88e-06	0.000126	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYCS—hematologic cancer	3.84e-06	0.000124	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.83e-06	0.000124	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.81e-06	0.000123	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SDC1—hematologic cancer	3.81e-06	0.000123	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.79e-06	0.000123	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.72e-06	0.00012	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALB—hematologic cancer	3.67e-06	0.000119	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.64e-06	0.000118	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.64e-06	0.000118	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.63e-06	0.000118	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.59e-06	0.000116	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.54e-06	0.000115	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.54e-06	0.000115	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.51e-06	0.000114	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.51e-06	0.000114	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.46e-06	0.000112	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.45e-06	0.000112	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.43e-06	0.000111	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTP1—hematologic cancer	3.38e-06	0.00011	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.35e-06	0.000109	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NUP98—hematologic cancer	3.35e-06	0.000108	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.28e-06	0.000106	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.25e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.25e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.24e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NQO1—hematologic cancer	3.24e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CD44—hematologic cancer	3.24e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NUP214—hematologic cancer	3.22e-06	0.000104	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.18e-06	0.000103	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.18e-06	0.000103	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.17e-06	0.000103	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—MTR—hematologic cancer	3.16e-06	0.000102	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.16e-06	0.000102	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTM1—hematologic cancer	3.11e-06	0.000101	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NCOR1—hematologic cancer	3.11e-06	0.000101	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ENO2—hematologic cancer	3.1e-06	0.0001	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYCS—hematologic cancer	3.06e-06	9.92e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.06e-06	9.91e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.04e-06	9.86e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTT1—hematologic cancer	3e-06	9.74e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.94e-06	9.52e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.83e-06	9.18e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.81e-06	9.11e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTEN—hematologic cancer	2.8e-06	9.07e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—MTHFR—hematologic cancer	2.75e-06	8.9e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.74e-06	8.87e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.7e-06	8.74e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.69e-06	8.71e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—EP300—hematologic cancer	2.67e-06	8.65e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALB—hematologic cancer	2.65e-06	8.6e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.61e-06	8.46e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.55e-06	8.28e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.54e-06	8.22e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.5e-06	8.09e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CD44—hematologic cancer	2.5e-06	8.09e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.48e-06	8.04e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.48e-06	8.04e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.48e-06	8.03e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.36e-06	7.66e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.36e-06	7.66e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.35e-06	7.61e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.34e-06	7.59e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.31e-06	7.47e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.19e-06	7.1e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.19e-06	7.1e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CREBBP—hematologic cancer	2.14e-06	6.93e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.08e-06	6.75e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.08e-06	6.73e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALB—hematologic cancer	2.05e-06	6.65e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.03e-06	6.57e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTEN—hematologic cancer	2.02e-06	6.56e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALB—hematologic cancer	2e-06	6.49e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.98e-06	6.4e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.97e-06	6.39e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.96e-06	6.36e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.93e-06	6.26e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—EP300—hematologic cancer	1.93e-06	6.25e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.91e-06	6.2e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.91e-06	6.2e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.91e-06	6.2e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.84e-06	5.97e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.81e-06	5.87e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.77e-06	5.73e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.71e-06	5.53e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.69e-06	5.48e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.62e-06	5.25e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—AKT1—hematologic cancer	1.61e-06	5.23e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALB—hematologic cancer	1.6e-06	5.18e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTEN—hematologic cancer	1.56e-06	5.07e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.53e-06	4.95e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTEN—hematologic cancer	1.53e-06	4.95e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—EP300—hematologic cancer	1.49e-06	4.84e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—EP300—hematologic cancer	1.46e-06	4.72e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.43e-06	4.63e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.42e-06	4.6e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.41e-06	4.57e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.32e-06	4.27e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.25e-06	4.05e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALB—hematologic cancer	1.23e-06	4e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTEN—hematologic cancer	1.22e-06	3.95e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.18e-06	3.82e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—AKT1—hematologic cancer	1.17e-06	3.78e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—EP300—hematologic cancer	1.16e-06	3.77e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.1e-06	3.58e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.09e-06	3.53e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.08e-06	3.49e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTEN—hematologic cancer	9.41e-07	3.05e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—AKT1—hematologic cancer	9.02e-07	2.92e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—EP300—hematologic cancer	8.97e-07	2.91e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—AKT1—hematologic cancer	8.8e-07	2.85e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.6e-07	2.79e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—AKT1—hematologic cancer	7.03e-07	2.28e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.64e-07	2.15e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—AKT1—hematologic cancer	5.42e-07	1.76e-05	CbGpPWpGaD
